Christopher D.  Brown net worth and biography

Christopher Brown Biography and Net Worth

CTO of 908 Devices
Dr. Chris Brown is a co-founder, VP and CTO of 908 Devices Inc. Prior to founding 908 Devices, Chris was a platform architect at Apple in California leading investigations into future-gen hardware/software technologies. Before joining Apple, he headed Product Development and Engineering at Ahura Scientific and later Thermo Fisher Scientific, which acquired Ahura Scientific in 2010. Joining Ahura in 2004 he established the company’s core embedded analytics and chemometrics capability, led product and market development for the pharmaceutical/industrial vertical, and established the international applications, and scientific support teams. Prior to Ahura, Chris held several senior leadership roles at InLight Solutions developing multiple clinical, in-vivo and non-invasive biodiagnostic products across a range of imaging and spectroscopic modalities. He has published some 150 papers and presentations, and more than 30 granted/pending patents. Chris received his B.Sc. from Brandon University and Ph.D. in Chemistry from Dalhousie University where he developed chemometric techniques for mass spectrometry and chromatography.

What is Christopher D. Brown's net worth?

The estimated net worth of Christopher D. Brown is at least $2.44 million as of December 19th, 2023. Dr. Brown owns 890,510 shares of 908 Devices stock worth more than $2,439,997 as of November 21st. This net worth approximation does not reflect any other investments that Dr. Brown may own. Additionally, Dr. Brown receives an annual salary of $459,700.00 as CTO at 908 Devices. Learn More about Christopher D. Brown's net worth.

How old is Christopher D. Brown?

Dr. Brown is currently 49 years old. There are 4 older executives and no younger executives at 908 Devices. The oldest executive at 908 Devices is Ms. Barbara Russo, Vice President of Marketing & Corporate Communications, who is 61 years old. Learn More on Christopher D. Brown's age.

What is Christopher D. Brown's salary?

As the CTO of 908 Devices Inc., Dr. Brown earns $459,700.00 per year. There are 3 executives that earn more than Dr. Brown. The highest earning executive at 908 Devices is Dr. Kevin J. Knopp Ph.D., Co-Founder, CEO, President & Director, who commands a salary of $761,120.00 per year. Learn More on Christopher D. Brown's salary.

How do I contact Christopher D. Brown?

The corporate mailing address for Dr. Brown and other 908 Devices executives is , , . 908 Devices can also be reached via phone at 857-254-1500 and via email at [email protected]. Learn More on Christopher D. Brown's contact information.

Has Christopher D. Brown been buying or selling shares of 908 Devices?

Christopher D. Brown has not been actively trading shares of 908 Devices in the last ninety days. Learn More on Christopher D. Brown's trading history.

Who are 908 Devices' active insiders?

Are insiders buying or selling shares of 908 Devices?

In the last year, 908 Devices insiders bought shares 3 times. They purchased a total of 30,000 shares worth more than $178,500.00. In the last year, insiders at the sold shares 6 times. They sold a total of 40,346 shares worth more than $324,982.08. The most recent insider tranaction occured on May, 13th when CEO Kevin J Knopp bought 10,000 shares worth more than $64,200.00. Insiders at 908 Devices own 27.7% of the company. Learn More about insider trades at 908 Devices.

Information on this page was last updated on 5/13/2024.

Christopher D. Brown Insider Trading History at 908 Devices

See Full Table

Christopher D. Brown Buying and Selling Activity at 908 Devices

This chart shows Christopher D. Brown's buying and selling at 908 Devices by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

908 Devices Company Overview

908 Devices logo
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Read More

Today's Range

Now: $2.74
Low: $2.52
High: $2.82

50 Day Range

MA: $3.34
Low: $2.34
High: $3.91

2 Week Range

Now: $2.74
Low: $2.19
High: $12.51

Volume

543,857 shs

Average Volume

210,283 shs

Market Capitalization

$95.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.98